On October 25, 2023, Karin Walker, the Chief Accounting Officer of Prothena Corp PLC (NASDAQ:PRTA), sold 5,000 shares of the company. This move is part of a larger trend of insider selling at Prothena Corp PLC, as we will explore in this article.
Karin Walker has been with Prothena Corp PLC for several years, serving in the role of Chief Accounting Officer. Her responsibilities include overseeing the company's financial reporting, internal controls, and compliance with regulatory standards. Her insider status provides her with a unique perspective on the company's financial health and future prospects.
Prothena Corp PLC is a clinical-stage neuroscience company engaged in the discovery and development of novel therapies with the potential to fundamentally change the course of progressive, life-threatening diseases. Fueled by its deep scientific understanding built over decades of neuroscience research, the company is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged.
Over the past year, Karin Walker has sold a total of 70,000 shares and has not purchased any shares. This trend is mirrored in the broader insider transaction history for Prothena Corp PLC, which shows zero insider buys and 59 insider sells over the past year.
https://finance.yahoo.com/news/insider-sell-karin-walker-sells-090258648.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.